<code id='A4AE648444'></code><style id='A4AE648444'></style>
    • <acronym id='A4AE648444'></acronym>
      <center id='A4AE648444'><center id='A4AE648444'><tfoot id='A4AE648444'></tfoot></center><abbr id='A4AE648444'><dir id='A4AE648444'><tfoot id='A4AE648444'></tfoot><noframes id='A4AE648444'>

    • <optgroup id='A4AE648444'><strike id='A4AE648444'><sup id='A4AE648444'></sup></strike><code id='A4AE648444'></code></optgroup>
        1. <b id='A4AE648444'><label id='A4AE648444'><select id='A4AE648444'><dt id='A4AE648444'><span id='A4AE648444'></span></dt></select></label></b><u id='A4AE648444'></u>
          <i id='A4AE648444'><strike id='A4AE648444'><tt id='A4AE648444'><pre id='A4AE648444'></pre></tt></strike></i>

          hotspot

          hotspot

          author:comprehensive    Page View:8795
          Photography of the US department of health and human services in Silver Spring MD
          Manuel Balce Ceneta/AP

          An increasing number of medical device companies are submitting fabricated and unreliable data, the Food and Drug Administration noted Tuesday morning. The data comes from third-party labs hired by device firms to test the quality of their products.

          Triple-check your data or we’ll reject your device, the FDA warned.

          advertisement

          The goal of third-party testing is to ensure a device meets the FDA’s standards in a range of areas, including biocompatibility, sterility, and mechanical performance. The agency wrote that it has noticed an uptick in false data submissions in recent years, particularly from facilities based in China and India. In some cases, the facilities will send data copied from previous device submissions.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          The high cost of giving birth even with insurance
          The high cost of giving birth even with insurance

          AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

          read more
          Elevance, private equity launch primary care company
          Elevance, private equity launch primary care company

          MichaelConroy/APThesedays,thesurefirewaytogetaheadinhealthinsuranceistobecomeahealthcareprovider,and

          read more
          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more

          Readout Newsletter: The latest on Moderna, Apellis, and Merck

          JakubPorzycki/NurPhotoviaAPWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetou